Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cisplatin (platinol) (1 trial)
gemcitabine (gemzar) (1 trial)
vinorelbine (navelbine) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Trials (1 total)
Trial APIs (3 total)